BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11676130)

  • 1. [Inflammatory mediators (leukotrienes, thromboxane A2, tachykinins and others)].
    Kohno S; Nabe T
    Nihon Rinsho; 2001 Oct; 59(10):1906-12. PubMed ID: 11676130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
    Jonsson EW
    Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characteristics of cysteinyl-leukotriene receptor subtypes.
    Bäck M
    Life Sci; 2002 Jun; 71(6):611-22. PubMed ID: 12072150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotriene synthesis inhibitors versus antagonists: the pros and cons.
    Steinke JW; Culp JA
    Curr Allergy Asthma Rep; 2007 May; 7(2):126-33. PubMed ID: 17437683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of leukotrienes in asthma pathophysiology.
    Bisgaard H
    Pediatr Pulmonol; 2000 Aug; 30(2):166-76. PubMed ID: 10922142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review on leukotrienes and their receptors with reference to asthma.
    Singh RK; Tandon R; Dastidar SG; Ray A
    J Asthma; 2013 Nov; 50(9):922-31. PubMed ID: 23859232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional studies of leukotriene receptors in vascular tissues.
    Walch L; Norel X; Gascard JP; Brink C
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S107-11. PubMed ID: 10673237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotriene pathway genetics and pharmacogenetics in allergy.
    Duroudier NP; Tulah AS; Sayers I
    Allergy; 2009 Jun; 64(6):823-39. PubMed ID: 19416143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leukotriene modifiers].
    Minoguchi K; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1979-85. PubMed ID: 11676142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene modifiers for asthma treatment.
    Montuschi P; Peters-Golden ML
    Clin Exp Allergy; 2010 Dec; 40(12):1732-41. PubMed ID: 21059119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study on bronchial asthma and leukotriene antagonists].
    Yokoyama A
    Nihon Naika Gakkai Zasshi; 2004 Dec; 93(12):2656-61. PubMed ID: 15658499
    [No Abstract]   [Full Text] [Related]  

  • 13. [Zafirlukast (Accolate): a review of its pharmacological and clinical profile].
    Murata Y; Sugimoto O
    Nihon Yakurigaku Zasshi; 2002 Apr; 119(4):247-58. PubMed ID: 11979731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Leukotrienes: potential therapeutic targets in cardiovascular diseases].
    Bäck M
    Bull Acad Natl Med; 2006 Oct; 190(7):1511-8; discussion 1518-21. PubMed ID: 17450683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotriene and thromboxane antagonists.
    Obata T; Yamashita N; Nakagawa T
    Clin Rev Allergy; 1994; 12(1):79-93. PubMed ID: 8069817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the human cysteinyl leukotriene CysLT1 receptor.
    Lynch KR; O'Neill GP; Liu Q; Im DS; Sawyer N; Metters KM; Coulombe N; Abramovitz M; Figueroa DJ; Zeng Z; Connolly BM; Bai C; Austin CP; Chateauneuf A; Stocco R; Greig GM; Kargman S; Hooks SB; Hosfield E; Williams DL; Ford-Hutchinson AW; Caskey CT; Evans JF
    Nature; 1999 Jun; 399(6738):789-93. PubMed ID: 10391245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of asthma with drugs modifying the leukotriene pathway.
    Drazen JM; Israel E; O'Byrne PM
    N Engl J Med; 1999 Jan; 340(3):197-206. PubMed ID: 9895400
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacodynamic properties of leukotriene receptor antagonists.
    Nicosia S
    Monaldi Arch Chest Dis; 1999 Jun; 54(3):242-6. PubMed ID: 10441979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophils and cysteinyl leukotrienes.
    Bandeira-Melo C; Weller PF
    Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):135-43. PubMed ID: 12895596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The leukotriene receptors as therapeutic targets of inflammatory diseases.
    Sasaki F; Yokomizo T
    Int Immunol; 2019 Aug; 31(9):607-615. PubMed ID: 31135881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.